Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07190352 · ClinicalTrials.gov registry record · NA

Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT07190352 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07190352, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The primary aims of this study are to investigate the behavioral effects of applying targeted transcranial magnetic stimulation (TMS) to a node of the brain network subserving attention in schizophrenia and schizoaffective disorder and to correlate these effects to changes in brain network connectivity. Assumptions: -Cerebral activity can be investigated through the correlated activity of cortical nodes that constitute functional brain networks -Behavior can be correlated to the strength of correlated activity between and within nodes of these cortical networks -TMS to targeted nodes leads to changes in patterns of activity in these cortical networks Hypothesis: TMS to a node of the attention network in schizophrenia or schizoaffective disorder will influence network connectivity leading to measurable and predictable effects on attention.

Interventions

  • DEVICE Sham rTMS
  • DEVICE iTBS to the DMN
  • DEVICE cTBS to the DMN

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-10-04
Est. Completion 2022-10-03
Phase NA

What the Registry Record Tells You About NCT07190352

The ClinicalTrials.gov registry entry for NCT07190352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Sham rTMS is the first listed.

NCT07190352 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07190352 about?

NCT07190352 is a clinical study titled "Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia". The primary aims of this study are to investigate the behavioral effects of applying targeted transcranial magnetic stimulation (TMS) to a node of the brain network subserving attention in schizophrenia and schizoaffective disorder and to correlate these effects to changes in brain network connectiv...

What is the current status of trial NCT07190352?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-10-04. Estimated completion is 2022-10-03.

What interventions are being tested in trial NCT07190352?

The interventions under investigation include: Sham rTMS (DEVICE), iTBS to the DMN (DEVICE), cTBS to the DMN (DEVICE).

Who is sponsoring clinical trial NCT07190352?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.